JMP Securities Reaffirms “Market Perform” Rating for Vor Biopharma (NYSE:VOR)
Vor Biopharma (NYSE:VOR – Get Free Report)‘s stock had its “market perform” rating restated by stock analysts at JMP Securities in a research report issued to clients and investors on Friday,Benzinga reports. They presently have a $6.00 target price on the stock. A number of other brokerages also recently issued reports on VOR. Stifel Nicolaus […]
Vor Biopharma (NYSE:VOR – Get Free Report)‘s stock had its “market perform” rating restated by stock analysts at JMP Securities in a research report issued to clients and investors on Friday,Benzinga reports. They presently have a $6.00 target price on the stock. A number of other brokerages also recently issued reports on VOR. Stifel Nicolaus […]
